Skip to main content

Advertisement

SpringerLink
Log in

Small-intestinal necrosis due to non-occlusive mesenteric ischemia with diabetic ketoacidosis after quetiapine treatment

  • Case Report
  • Published:
Diabetology International Aims and scope Submit manuscript

Abstract

We report a 66-year-old male who developed diabetic ketoacidosis (DKA) and necrosis of the small intestine due to non-occlusive mesenteric ischemia (NOMI), 3 months after starting quetiapine treatment. He was transferred to our hospital and diagnosed as diabetic for the first time, associated with DKA. Despite improvement in DKA, abdominal pain worsened gradually 10 h after hospitalization. Computed tomography (CT) revealed bowel emphysema, and gas out of the gut wall, in the mesenteric veins and the intrahepatic portal vein, suggesting intestinal necrosis. He survived because of resection of necrotic small-intestinal tissue and he finally required no diabetes treatment. Mesenteric arteries were patent with good palpitation without occlusion or thrombosis, and pathological findings showed ischemic enteritis, which is consistent with NOMI. DKA is a rare but serious side effect of second-generation antipsychotic medications (SGAMs) such as quetiapine, which can result in NOMI: a life-threatening complication. We must keep in mind that the plasma glucose concentration may increase in patients taking SGAMs, or that NOMI may occur concurrently if DKA develops.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Leucht S, Corves C, Arbter D, Engel RR, Li C, Davis JM. Second-generation versus first-generation antipsychotic drugs for schizophrenia. Lancet. 2009;373:31–41.

    Article  CAS  PubMed  Google Scholar 

  2. Hawkins SB, Bucklin M, Muzyk AJ. Quetiapine for the treatment of delirium. J Hosp Med. 2013;8:215–20.

    Article  PubMed  Google Scholar 

  3. Kishi T, Hirota T, Matsunaga S, Iwata N. Antipsychotic medications for the treatment of delirium: a systematic review and meta-analysis of randomized controlled trials. J Neurol Neurosurg Psychiatry. 2016;87:767–74.

    Article  PubMed  Google Scholar 

  4. Lipscombe LL, Austin PC, Alessi-Severini S, et al. Atypical antipsychotics and hyperglycemic emergencies: multicenter, retrospective cohort study of administrative data. Schizophr Res. 2014;154:54–60.

    Article  PubMed  Google Scholar 

  5. Guenette M, Hahn M, Cohn T, Teo C, Remington G. Atypical antipsychotics and diabetic ketoacidosis: a review. Psychopharmacology. 2013;226:1–12.

    Article  CAS  PubMed  Google Scholar 

  6. Anotonia V, Martina RK, Maja B, Martina MO. Diabetic ketoacidosis associated with antipsychotic drugs: case reports and a review of literature. Psychiatria Danubina. 2017;29(2):121–35.

    Article  Google Scholar 

  7. Ministry of Health, Labour and Welfare. Diabetic ketoacidosis and coma due to hyperglycemia during quetiapine treatment. 2002. http://www.mhlw.go.jp/houdou/2002/11/h1107-1.html. Last accessed 2 Aug 2018 (in Japanese).

  8. Buchholz S, Morrow AF, Coleman PL. Atypical antipsychotic-induced diabetes mellitus: an update on epidemiology and postulated mechanisms. Intern med J. 2008;38:602–6.

    Article  CAS  PubMed  Google Scholar 

  9. Tecott LH, Sum LM, Akana SF. Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors. Nature. 1995;374:542–6.

    Article  CAS  PubMed  Google Scholar 

  10. Orthen-Gambill N, Saalomon M. Differential effects of psychotropic drugs on feeding in rats: is histamine blockade involved? Pharmacol Biochem Behav. 1990;36:837–41.

    Article  CAS  PubMed  Google Scholar 

  11. Newcomer JW, Haupt DW, Fucetola R, et al. Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia. Arch Gen Psychiatry. 2002;59:337–45.

    Article  CAS  PubMed  Google Scholar 

  12. Sowell MO, Mukhopadhyay N, Cavazzoni P, et al. Hyperglycemic clamp assessment of insulin secretory responses in normal subjects treated with olanzapine, risperidone, or placebo. J Clin Endocrinol Metab. 2002;87:2918–23.

    Article  CAS  PubMed  Google Scholar 

  13. Pierides M. Clozapine monotherapy and ketoacidosis. Br J Psychiatry J Ment Sci. 1997;171:90–1.

    Article  CAS  Google Scholar 

  14. Nicolai J, Smith SJ, Keunen RW. Simultaneous side effects of both clozapine and valproate. Intensive Care Med. 2001;27:943.

    Article  CAS  PubMed  Google Scholar 

  15. American Diabetes Association, American Psychiatric Association, American Association of Clinical Endoclinologist, North American Association for the Study of Obesity. Concensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care. 2004;27:596–601.

    Article  Google Scholar 

  16. Thompson JS, Bragg LE, West WW. Serum enzyme levels during intestinal ischemia. Ann Surg. 1990;211:369–73.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Altinyollar H, Boyabatli M, Berberoğlu U. D-dimer as a marker for early diagnosis of acute mesenteric ischemia. Thromb Res. 2006;117:463–7.

    Article  CAS  PubMed  Google Scholar 

  18. Karabulut K, Gul M, Dundar ZD, Cander B, et al. Diagnostic and prognostic value of procalcitonin and phosphorus in acute mesenteric ischemia. Ulus Travma Acil Cerrahi Derg. 2011;17:193–8.

    Article  PubMed  Google Scholar 

  19. Adaba F, Askari A, Dastur J, et al. Mortality after acute primary mesenteric infarction: a systematic review and meta-analysis of observational studies. Colorectal Dis. 2015;17:566–77.

    Article  CAS  PubMed  Google Scholar 

  20. Trompeter M, Brazda T, Remy CT, Vestring T, Reimer P. Non-occlusive mesenteric ischemia: etiology, diagnosis, and interventional therapy. Eur Radiol. 2000;12:1179–87.

    Article  Google Scholar 

  21. Ashrafi M, Hashemipour M, Moadab MH, Jamshidi M, Hosseinpour M. Ischemic intestinal necrosis in a five-year-old girl with diabetic ketoacidosis. Arch Iran Med. 2007;10:529–31.

    PubMed  Google Scholar 

  22. Gocho N, Aoki E, Okada C, et al. Non-occlusive mesenteric ischemia with diabetic ketoacidosis and lactic acidosis following the administration of a sodium glucose co-transporter 2 inhibitor. Intern Med. 2016;55:1755–60.

    Article  PubMed  Google Scholar 

  23. Dimeglio LA, Chaet MS, Quigley CA, Grosfeld JL. Massive ischemic intestinal necrosis at the onset of diabetes mellitus with ketoacidosis in a three-year-old girl. J Pediatr Surg. 2003;38:11537–9.

    Article  Google Scholar 

  24. Worly JM, Fortenberry JD, Hansen I, Chambliss CR, Stockwell J. Deep venous thrombosis in children with diabetic ketoacidosis and femoral central venous catheters. Pediatrics. 2004;113:57–60.

    Article  Google Scholar 

  25. Ferriss JB, O’Hare JA, Kelleher CC, et al. Diabetic control and the renin-angiotensin system, catecholamines, and blood pressure. Hypertension. 1985;7:1158–63.

    Article  Google Scholar 

  26. Newcomer JW. Metabolic considerations in the antipsychotic medications: a review of recent evidence. J Clin Psychiatry. 2007;68(suppl 1):20–7.

    CAS  PubMed  Google Scholar 

  27. Findikli E, Gökçe M, Nacitarhan V, et al. Arterial stiffness in patients taking second generation antipsychotics. Clin Psychopharmacol Neurosci. 2016;14:365–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Mitsuyoshi A, Obama K, Shinkura N, Ito T, Zaima M. Survival in nonocclusive mesenteric ischemia: early diagnosis by multidetector row computed tomography and early treatment with continuous intravenous high-dose prostaglandin E1. Ann Surg. 2007;246:229–35.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Takai T, Takebe R, Ogata M, Katsuyama E, Nakamura T. A type 2 Diabetic patient with non-occlusive mesenteric ischemia probably induced by diabetic ketoacidosis due to prednisolone intake. J Jpn Diabets Soc. 2013;56:298–304.

    Google Scholar 

  30. Kamatani N, Katoh T, Sawai Y, et al. A case of diabetic ketoacidosis comorbid with nonocclusive mesenteric ischemia in a severely dehydrated type 2 diabetic patient. J Jpn Diabets Soc. 2013;56:886–91.

    Google Scholar 

  31. Kim D, Ryba NL, Kalabalik F, Westrich L. Critical review of the use of second-generation antipsychotics in obsessive-compulsive and related disorders. Drugs R D. 2018;15:27. https://doi.org/10.1007/s40268-018-0246-8.

    Article  CAS  Google Scholar 

  32. Cho NH, Shaw JE, Karuranga S, et al. IDF diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271–81.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Endocrinology and Metabolism, Sumitomo Hospital, Osaka, 530-0005, Japan

    Yoshito Itoh, Sachiko Tamba, Koji Yamamoto, Yuya Yamada & Yuji Matsuzawa

  2. General Medicine, Sumitomo Hospital, Osaka, Japan

    Ryo Sagawa, Hirotaka Kinoshita & Koji Yamamoto

Authors
  1. Yoshito Itoh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ryo Sagawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hirotaka Kinoshita
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sachiko Tamba
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Koji Yamamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yuya Yamada
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yuji Matsuzawa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yoshito Itoh.

Ethics declarations

Conflict of interest

The authors state that they have no conflict of interest (COI).

Human rights statement

All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions. Informed consent was obtained for the publication of the case report.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Itoh, Y., Sagawa, R., Kinoshita, H. et al. Small-intestinal necrosis due to non-occlusive mesenteric ischemia with diabetic ketoacidosis after quetiapine treatment. Diabetol Int 10, 225–230 (2019). https://doi.org/10.1007/s13340-018-0386-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13340-018-0386-7

Keywords

Search

Navigation